BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in ...
New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback